{"abstract":"The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of a final guidance for immediate implementation entitled \"Recommendations To Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps).\" FDA is issuing this guidance to provide establishments making donor eligibility determinations with recommendations to reduce the risk of transmission of infections due to sepsis by HCT/Ps. This notice is being issued to respond to a public health safety concern and to address the urgent need for updated recommendations in making a donor eligibility determination when screening a donor for clinical evidence of sepsis and clinical signs to consider.","action":"Notice of availability.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2025/01/07/2024-31538.html","cfr_references":[],"citation":"90 FR 1141","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The announcement of the guidance is published in the Federal Register on January 7, 2025.","disposition_notes":null,"docket_ids":["Docket No. FDA-2024-D-3067"],"dockets":[{"supporting_documents":[{"title":"Reference 27 - Antonov, D., et al., 2020, The Rash that Becomes Purpuric, Petechial, Hemorrhagic, or Ecchymotic, Clin Dermatol, 38(1): 3-18. doi: 10.1016/j.clindermatol.2019.07.","document_id":"FDA-2024-D-3067-0030"},{"title":"Reference 26 - Santistevan, J., et al., 2017, Rash Decisions: An Approach to Dangerous Rashes Based on Morphology, J Emerg Med, 52(4): 457-71. DOI: 10.1016/j.jemermed.2016.10.027.","document_id":"FDA-2024-D-3067-0029"},{"title":"Reference 25 - Lyon, M., Kaul, D., et al., for the Disease Transmission Advisory Committee (DTAC), Organ Procurement & Transplantation Network (OPTN). Infectious disease transmission from organ donors with meningitis or encephalitis. Abstract #572, 2011 American Transplant Congress, Philadelphia, PA.","document_id":"FDA-2024-D-3067-0028"},{"title":"Reference 24 - Basavaraju, SV., Kuehnert, MJ., Zaki, SR., Sejvar, JJ. Encephalitis caused by pathogens transmitted through organ transplants, United States, 2002-2013. Emerg Infect Dis. 2014 Sep;20(9):1443-51. doi: 10.3201/eid2009.131332.","document_id":"FDA-2024-D-3067-0027"},{"title":"Reference 23 - Organ Procurement & Transplantation Network (OPTN), Health Resources & Services Administration (HRSA). Guidance for Recognizing Central Nervous System Infections in Potential Deceased Organ Donors, What to Consider During Donor Evaluation and Organ Offers. https://optn.transplant.hrsa.gov/professionals/by-topic/guidance/guidance-for-recognizing-central-nervous","document_id":"FDA-2024-D-3067-0026"},{"title":"Reference 21 - Gando, S., et al., 2020, The SIRS Criteria Have Better Performance for Predicting Infection than qSOFA Scores in the Emergency Department, Nature Research, 10(1): 8095. doi: 10.1038/s41598-020-64314-8.","document_id":"FDA-2024-D-3067-0024"},{"title":"Reference 20 - Dugar, S., et al., 2020, Sepsis and Septic Shock: Guideline-Based Management, Cleveland Clinic J Med, 87(1): 53-64. https://www.ccjm.org/content/87/1/53.","document_id":"FDA-2024-D-3067-0023"},{"title":"Reference 18 - Donnelly JP, Locke JE, MacLennan PA, et al., Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis. Clin Infect Dis 2016; 63:186.","document_id":"FDA-2024-D-3067-0021"},{"title":"Reference 16 - Infection in the solid organ transplant recipients. Fishman JA. https://www.uptodate.com/contents/infection-in-the-solid-organ-transplant-recipient (accessed August 31, 2023).","document_id":"FDA-2024-D-3067-0019"},{"title":"Reference 15 - Centers for Disease Control and Prevention, 2005, Fatal Bacterial Infections Associated with Platelet Transfusions --- United States, 2004, Morb Mortal Wkly Rep, 54(7): 168-70. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5407a2.htm. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5407a2.htm","document_id":"FDA-2024-D-3067-0018"}],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":null,"updated_at":"2025-01-07T11:56:33.469-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2024-D-3067-0001","allow_late_comments":false,"id":"FDA-2024-D-3067-0001","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":28,"id":"FDA-2024-D-3067","title":"Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Guidance for Industry; Availability"}],"document_number":"2024-31538","effective_on":null,"end_page":1143,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2025/01/07/2024-31538.xml","html_url":"https://www.federalregister.gov/documents/2025/01/07/2024-31538/recommendations-to-reduce-the-risk-of-transmission-of-disease-agents-associated-with-sepsis-by-human","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2024-31538?publication_date=2025-01-07","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2025-01-07/2024-31538/mods.xml","not_received_for_publication":null,"page_length":3,"page_views":{"count":227,"last_updated":"2026-11-22 08:15:04 -0500"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-01-07/pdf/2024-31538.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-31538.pdf?1736171122","publication_date":"2025-01-07","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2025/01/07/2024-31538.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Reference 27 - Antonov, D., et al., 2020, The Rash that Becomes Purpuric, Petechial, Hemorrhagic, or Ecchymotic, Clin Dermatol, 38(1): 3-18. doi: 10.1016/j.clindermatol.2019.07.","document_id":"FDA-2024-D-3067-0030"},{"title":"Reference 26 - Santistevan, J., et al., 2017, Rash Decisions: An Approach to Dangerous Rashes Based on Morphology, J Emerg Med, 52(4): 457-71. DOI: 10.1016/j.jemermed.2016.10.027.","document_id":"FDA-2024-D-3067-0029"},{"title":"Reference 25 - Lyon, M., Kaul, D., et al., for the Disease Transmission Advisory Committee (DTAC), Organ Procurement & Transplantation Network (OPTN). Infectious disease transmission from organ donors with meningitis or encephalitis. Abstract #572, 2011 American Transplant Congress, Philadelphia, PA.","document_id":"FDA-2024-D-3067-0028"},{"title":"Reference 24 - Basavaraju, SV., Kuehnert, MJ., Zaki, SR., Sejvar, JJ. Encephalitis caused by pathogens transmitted through organ transplants, United States, 2002-2013. Emerg Infect Dis. 2014 Sep;20(9):1443-51. doi: 10.3201/eid2009.131332.","document_id":"FDA-2024-D-3067-0027"},{"title":"Reference 23 - Organ Procurement & Transplantation Network (OPTN), Health Resources & Services Administration (HRSA). Guidance for Recognizing Central Nervous System Infections in Potential Deceased Organ Donors, What to Consider During Donor Evaluation and Organ Offers. https://optn.transplant.hrsa.gov/professionals/by-topic/guidance/guidance-for-recognizing-central-nervous","document_id":"FDA-2024-D-3067-0026"},{"title":"Reference 21 - Gando, S., et al., 2020, The SIRS Criteria Have Better Performance for Predicting Infection than qSOFA Scores in the Emergency Department, Nature Research, 10(1): 8095. doi: 10.1038/s41598-020-64314-8.","document_id":"FDA-2024-D-3067-0024"},{"title":"Reference 20 - Dugar, S., et al., 2020, Sepsis and Septic Shock: Guideline-Based Management, Cleveland Clinic J Med, 87(1): 53-64. https://www.ccjm.org/content/87/1/53.","document_id":"FDA-2024-D-3067-0023"},{"title":"Reference 18 - Donnelly JP, Locke JE, MacLennan PA, et al., Inpatient Mortality Among Solid Organ Transplant Recipients Hospitalized for Sepsis and Severe Sepsis. Clin Infect Dis 2016; 63:186.","document_id":"FDA-2024-D-3067-0021"},{"title":"Reference 16 - Infection in the solid organ transplant recipients. Fishman JA. https://www.uptodate.com/contents/infection-in-the-solid-organ-transplant-recipient (accessed August 31, 2023).","document_id":"FDA-2024-D-3067-0019"},{"title":"Reference 15 - Centers for Disease Control and Prevention, 2005, Fatal Bacterial Infections Associated with Platelet Transfusions --- United States, 2004, Morb Mortal Wkly Rep, 54(7): 168-70. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5407a2.htm. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5407a2.htm","document_id":"FDA-2024-D-3067-0018"}],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2024-D-3067","supporting_documents_count":28,"docket_id":"FDA-2024-D-3067","document_id":"FDA-2024-D-3067-0001","regulation_id_number":null,"title":"Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps); Guidance for Industry; Availability","checked_regulationsdotgov_at":"2025-01-08T16:00:13Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":1141,"subtype":null,"title":"Recommendations To Reduce the Risk of Transmission of Disease Agents Associated With Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products; Guidance for Industry; Availability","toc_doc":"Recommendations to Reduce the Risk of Transmission of Disease Agents Associated with Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products","toc_subject":"Guidance","topics":[],"type":"Notice","volume":90}